Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron Lee

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Journal of Urology|October 25, 2021
Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional ExperienceAbhinav Khanna, Tanner Miest, Vidit Sharma, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tractPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.
Clinical Genitourinary Cancer|March 20, 2018
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial CarcinomaHamid Emamekhoo, Puneet Dhillon, Dharmesh Gopalakrishnan, et al.
Clinical Genitourinary Cancer|April 29, 2020
Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall SurvivalJaleh Fallah, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.
Clinical and Translational Radiation Oncology|October 15, 2024
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancerPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.
Targeted Oncology|March 25, 2020
Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial CarcinomaIris Y Sheng, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.
Cancer Medicine|January 20, 2025
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary TractMohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke, et al.
The Journal of Urology|January 19, 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial CarcinomaAditya Bagrodia, Eugene K Cha, John P Sfakianos, et al.
Circulation|January 29, 2014
Risk stratification for sudden cardiac death: a plan for the futureJeffrey J Goldberger, Anirban Basu, Robin Boineau, et al.
Nature|May 19, 2026
Accelerating scientific discovery with Co-ScientistJuraj Gottweis, Wei-Hung Weng, Alexander Daryin, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of Urology|October 25, 2021
Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional ExperienceAbhinav Khanna, Tanner Miest, Vidit Sharma, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tractPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.
Clinical Genitourinary Cancer|March 20, 2018
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial CarcinomaHamid Emamekhoo, Puneet Dhillon, Dharmesh Gopalakrishnan, et al.
Clinical Genitourinary Cancer|April 29, 2020
Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall SurvivalJaleh Fallah, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.
Clinical and Translational Radiation Oncology|October 15, 2024
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancerPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.
Targeted Oncology|March 25, 2020
Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial CarcinomaIris Y Sheng, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.
Cancer Medicine|January 20, 2025
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary TractMohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke, et al.
The Journal of Urology|January 19, 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial CarcinomaAditya Bagrodia, Eugene K Cha, John P Sfakianos, et al.
Circulation|January 29, 2014
Risk stratification for sudden cardiac death: a plan for the futureJeffrey J Goldberger, Anirban Basu, Robin Boineau, et al.
Nature|May 19, 2026
Accelerating scientific discovery with Co-ScientistJuraj Gottweis, Wei-Hung Weng, Alexander Daryin, et al.
Pageof 6